Register entry
DIZAL PHARMACEUTICAL CO LTD
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 6
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
6| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11007198 | ZEGFROVYsunvozertinib | substance, product | Jan 2039 |
| 11504375 | ZEGFROVYsunvozertinib | substance, product | Jan 2039 |
| 11896597 | ZEGFROVYsunvozertinib | substance, product | Jan 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| ZEGFROVYSUNVOZERTINIB | NCE New chemical entity | Jul 2030 |
Enquiry
Common questions
- Is DIZAL PHARMACEUTICAL CO LTD FDA approved?
- DIZAL PHARMACEUTICAL CO LTD holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.